(1S,2R,5S,7R,9R,10S,14R,15S,19S)-19-Ethyl-15-hydroxy-14-methyl-7-[(2R,3R,4R,5S,6S)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione
Spinosyn A17-pseudoaglycone is a fully characterized chemical compound used as a reference standard of API Spinosad. The standard offered is compliant with regulatory guidelines. Spinosyn A17-pseudoaglycone is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 131929-68-5
Related products
Spinosad (Mixture of Spinosyn A and Spinosyn D)
M.F.
M.W. 731.97 + 746.00
CAT# AR-S01859
CAS# 168316-95-8
